Jan. 17, 2018
Certis USA announced that it entered into a global Licensing Agreement with the University of Szeged in Hungary for a novel, patented biopesticide strain, Bacillus mojavensis
strain R3B. Certis USA will develop, manufacture and market the novel strain as a biopesticide product for agricultural and horticultural uses worldwide.
The patented strain has a unique profile and has been found to be an effective antagonist against many pathogens, in particular soil-borne diseases, that effect fruits and vegetables. The university has identified the strain as copper resistant, allowing it to be combined with copper pesticides for enhanced control of plant pathogens.
This agreement brings another innovative technology to Certis USA’s growing platform of biopesticides based on Bacillus technology, such as Bacillus thuringiensis, Bacillus amyloliquefaciens and Bacillus mycoides.